• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病-淋巴瘤细胞系中bcl-2 mRNA和蛋白的表达

Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.

作者信息

Steube K G, Jadau A, Teepe D, Drexler H G

机构信息

DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen), German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.

出版信息

Leukemia. 1995 Nov;9(11):1841-6.

PMID:7475272
Abstract

The expression of the proto-oncogene bcl-2 was examined in a panel of 75 continuous human leukemia-lymphoma cell lines originated from different hematopoietic cell types. The presence of the bcl-2 protein, as evidenced by Western blotting, and its mRNA, as determined by Northern blotting, were not restricted to cells with the chromosomal translocation t(14;18)(q32;q21), but were also detected in a large number of cell lines without t(14;18). The amount of the bcl-2 protein and mRNA in the cell lines with t(14;18) was in the same order of magnitude as in other bcl-2 expressing cell lines of the same lineage, but without the translocation. Bcl-2 was found in all types of hematopoietic cell lines which were assigned to the following lineages based on their phenotypical characteristics: pre-B, B, plasma, T, myeloid, monocytic, erythroid-megakaryocytic and Hodgkin's lymphoma derived cell lines. The levels of accumulated mRNA and protein corresponded fairly well in most of the cell lines examined. Our results suggest the notion that bcl-2 expression is widely present in hematopoietic cell lines without restriction to single lineages and, in fact, clearly independent of the chromosomal aberration t(14;18). It is conceivable that bcl-2 expression is a common feature in established hematopoietic cell lines and may contribute to their unlimited growth in vitro.

摘要

在一组源自不同造血细胞类型的75个人类白血病-淋巴瘤连续细胞系中检测了原癌基因bcl-2的表达。通过蛋白质印迹法证实存在bcl-2蛋白,通过Northern印迹法测定其mRNA,其表达不仅限于具有染色体易位t(14;18)(q32;q21)的细胞,在大量无t(14;18)的细胞系中也能检测到。有t(14;18)的细胞系中bcl-2蛋白和mRNA的量与同一谱系中其他表达bcl-2但无该易位的细胞系处于相同数量级。在根据表型特征归为以下谱系的所有类型造血细胞系中均发现了bcl-2:前B细胞、B细胞、浆细胞、T细胞、髓细胞、单核细胞、红系-巨核细胞系以及霍奇金淋巴瘤衍生细胞系。在所检测的大多数细胞系中,积累的mRNA水平和蛋白水平相当吻合。我们的结果表明,bcl-2表达广泛存在于造血细胞系中,不限于单一谱系,实际上明显独立于染色体畸变t(14;18)。可以想象,bcl-2表达是已建立的造血细胞系的一个共同特征,可能有助于它们在体外的无限生长。

相似文献

1
Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.白血病-淋巴瘤细胞系中bcl-2 mRNA和蛋白的表达
Leukemia. 1995 Nov;9(11):1841-6.
2
Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Leukemia. 1996 Jan;10(1):150-8.
3
Expression of the FLT3 gene in human leukemia-lymphoma cell lines.FLT3基因在人白血病淋巴瘤细胞系中的表达。
Leukemia. 1994 May;8(5):885-8.
4
Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.在一种淋巴细胞性淋巴瘤细胞系中,通过染色体易位同时激活c-myc并使bcl-2失活。
Oncogene. 1990 Dec;5(12):1815-9.
5
Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.FLT3受体和FLT3配体在人白血病-淋巴瘤细胞系中的表达。
Leukemia. 1995 Aug;9(8):1368-72.
6
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.一种bcl-2/IgH反义转录本可使人类滤泡性淋巴瘤t(14;18)细胞系中的bcl-2基因表达失调。
Oncogene. 1996 Jul 4;13(1):105-15.
7
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.通过将两种致癌基因易位至同一免疫球蛋白重链基因座,在B细胞非霍奇金淋巴瘤细胞系中同时激活MYC和BCL2 。
Leukemia. 1996 Jul;10(7):1198-208.
8
Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes.在含有正常18号染色体或t(14;18)染色体的淋巴样细胞系中bcl-2基因表达的调控
Oncogene Res. 1989;4(4):271-82.
9
Expression of the monocyte-specific esterase gene in leukemia-lymphoma cell lines.单核细胞特异性酯酶基因在白血病-淋巴瘤细胞系中的表达。
Leukemia. 1993 Jan;7(1):58-62.
10
bcl-2 gene expression in hematopoietic cell differentiation.
Blood. 1992 Aug 1;80(3):768-75.

引用本文的文献

1
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells.泛 Bcl-2 抑制剂 obatoclax 促进急性髓系白血病细胞的分化和凋亡。
Invest New Drugs. 2020 Dec;38(6):1664-1676. doi: 10.1007/s10637-020-00931-4. Epub 2020 May 4.
2
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.zeta-晶状体蛋白是一种 bcl-2mRNA 结合蛋白,参与 T 细胞急性淋巴细胞白血病中 bcl-2 的过表达。
FASEB J. 2010 Jun;24(6):1852-65. doi: 10.1096/fj.09-140459. Epub 2010 Jan 26.
3
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
淋巴浆细胞淋巴瘤/华氏巨球蛋白血症患者一级亲属中淋巴增殖性疾病的风险:瑞典一项基于人群的研究
Blood. 2008 Oct 15;112(8):3052-6. doi: 10.1182/blood-2008-06-162768. Epub 2008 Aug 13.
4
Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA.核仁素在慢性淋巴细胞白血病细胞中的过表达诱导bcl2 mRNA的稳定性。
Blood. 2007 Apr 1;109(7):3069-75. doi: 10.1182/blood-2006-08-043257.